Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Regulatory News (CLIN)

  • There is currently no data for CLIN

Form 8.5 (EPT/NON-RI) CLINIGEN GROUP PLC

11 Mar 2022 10:18

RNS Number : 5079E
Barclays PLC
11 March 2022
Ā 

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS

(OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Name of exempt principal trader:

Ā 

BARCLAYS CAPITAL SECURITIES LTD

(b)

Name of offeror/offeree in relation to whose

CLINIGEN GROUP PLC

Ā 

relevant securities this form relates:

(c)

Name of the party to the offer with which exempt

Triley Bidco Limited (a newly-formed company indirectly owned by Triton Funds)

Ā 

principal trader is connected

Ā 

(d)

Date position held/dealing undertaken:

10 March 2022

(e)

In addition to the company in 1(b) above, is the exempt principal

NO

Ā 

Ā 

Ā 

trader making disclosures in respect of any other party to the offer?

Ā 

Ā 

Ā 

2.

POSITIONS OF THE EXEMPT PRINCIPAL TRADER

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Ā 

to which the disclosure relates following the dealing (if any)

Ā 

Ā 

Class of relevant security:

0.1p ordinary

Ā 

Ā 

Ā 

Interests

Short Positions

Ā 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Ā 

Ā 

Ā 

Ā 

Ā 

and/or controlled:

1,064,791

0.80%

251,018

0.19%

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(2)

Cash-settled derivatives:

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

104,563

0.08%

406,193

0.30%

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(3)

Stock-settled derivatives (including options)

Ā 

Ā 

Ā 

Ā 

Ā 

and agreements to purchase/sell:

0

0.00%

0

0.00%

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

TOTAL:

Ā 

1,169,354

0.88%

657,211

0.49%

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(b)

Rights to subscribe for new securities (including directors and other executive

Ā 

options)

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant security in relation to

Ā 

which subscription right exists

Ā 

Details, including nature of the rights

Ā 

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant

Ā 

Purchase/sale

Ā 

Total number of

Ā 

Highest price per unit

Lowest price per unit

security

Ā 

Ā 

Ā 

securities

Ā 

paid/received

paid/received

0.1p ordinary

Purchase

11,839

9.2075 GBP

9.2 GBP

0.1p ordinary

Sale

58,608

9.2092 GBP

9.2021 GBP

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(b)

Cash-settled derivative transactions

Ā 

Ā 

Ā 

Class of

Ā 

Product

Ā 

Nature of dealing

Ā 

Number of

Price per

relevant

Ā 

description

Ā 

Ā 

Ā 

reference

unit

security

Ā 

Ā 

Ā 

Ā 

Ā 

securities

Ā 

0.1p ordinary

Ā SWAP

Increasing Long

1,861

9.2005 GBP

0.1p ordinary

Ā SWAP

Increasing Long

2,473

9.2052 GBP

0.1p ordinary

Ā SWAP

Increasing Long

6,704

9.2074 GBP

0.1p ordinary

Ā SWAP

Increasing Long

15,788

9.2043 GBP

0.1p ordinary

Ā SWAP

Increasing Long

21,033

9.2008 GBP

0.1p ordinary

Ā CFD

Increasing Short

66

9.2012 GBP

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(c)

Stock-settled derivative transactions (including options)

Ā 

Ā 

(i)

Writing, selling, purchasing or varying

Ā 

Ā 

Ā 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Ā 

date

money

relevant

Ā 

selling,

securities

per unit

Ā 

Ā 

paid/

security

Ā 

varying etc

to which

Ā 

Ā 

Ā 

received

Ā 

Ā 

Ā 

option

Ā 

Ā 

Ā 

per unit

Ā 

Ā 

Ā 

relates

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(ii)

Exercising

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Ā 

Ā 

Ā 

securities

unit

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(d)

Other dealings (including subscribing for new securities)

Ā 

Ā 

Class of relevant

Ā 

Nature of Dealings

Ā 

Details

Price per unit (if

Ā 

security

Ā 

Ā 

Ā 

applicable)

Ā 

Ā 

Ā 

Ā 

Ā 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Ā 

Ā 

Ā 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

Ā 

Ā 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

Ā 

(i) the voting rights of any relevant securities under any option; or

Ā 

Ā 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

Ā 

Ā 

Ā 

Ā 

Ā 

NONE

(c)

Attachments

Ā 

Ā 

Ā 

Ā 

Ā 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

11Ā MarĀ 2022

Ā 

Ā 

Ā 

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
FEOBKDBDKBKDNND
Date   Source Headline
4th Apr 20224:54 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc_Amend
4th Apr 20223:29 pmRNSForm 8.3 - [Clinigen Group plc/Triley Bidco Ltd]
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 202212:31 pmGNWForm 8.3 - Clinigen Group PLC
4th Apr 202211:46 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc
4th Apr 202211:09 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
4th Apr 202210:59 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
4th Apr 202210:50 amRNSScheme Becomes Effective
4th Apr 20229:50 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
4th Apr 20229:19 amRNSForm 8.5 (EPT/RI) - Clinigen Group Plc
4th Apr 20227:30 amRNSSuspension - Clinigen Group PLC
1st Apr 20223:29 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:25 pmRNSForm 8.3 - Clinigen Group
1st Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:00 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20221:27 pmGNWForm 8.3 - Clinigen Group PLC
1st Apr 20221:09 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc
1st Apr 202210:59 amRNSForm 8.5 (EPT/NON-RI)-CLINIGEN GROUP PLC
1st Apr 202210:52 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 202210:22 amRNSForm 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 20229:56 amRNSForm 8.3 - Clinigen Group Plc
31st Mar 20225:52 pmRNSForm 8.5 (EPT/RI)- Clinigen Group plc Amend
31st Mar 20223:30 pmGNWForm 8.3 - Clinigen Group plc
31st Mar 20223:29 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:27 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 202212:54 pmRNSCourt Sanction of Scheme of Arrangement
31st Mar 202212:52 pmGNWForm 8.3 - Clinigen Group PLC
31st Mar 202211:11 amRNSForm 8.3 - CLINIGEN GROUP PLC
31st Mar 202211:09 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
31st Mar 202210:48 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
31st Mar 202210:41 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
31st Mar 202210:10 amRNSForm 8.3 - Clinigen Group Plc
30th Mar 20225:30 pmRNSClinigen Group
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
30th Mar 20222:42 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20221:44 pmGNWForm 8.3 - Clinigen Group PLC
30th Mar 202211:45 amRNSForm 8.5 (EPT/NON-RI)- Clinigen Group plc
30th Mar 202211:37 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
30th Mar 202211:19 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
30th Mar 202210:49 amRNSForm 8.3 - Clinigen Group PLC
30th Mar 202210:35 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
30th Mar 202210:34 amRNSForm 8.3 - Clinigen Group Plc
29th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
29th Mar 20222:48 pmRNSForm 8.3 - Clinigen Group Plc
29th Mar 20222:43 pmRNSForm 8.3 -Clinigen Group plc
29th Mar 20221:30 pmBUSForm 8.3 - CLINIGEN GROUP PLC
29th Mar 202212:55 pmGNWForm 8.3 - Clinigen Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.